This book delves into the dynamic and increasingly complex world of New Psychoactive Substances (NPS). Between 2009 and 2023, more than 1,250 distinct NPS were identified worldwide, with a record number reported in 2023 alone. This surge reflects a growing diversity, particularly in the categories of synthetic opioids (notably nitazenes), cannabinoids, and stimulants. The emergence of these substances presents significant challenges for public health, law enforcement, and regulatory frameworks, largely due to their novel chemical structures, limited detectability, and serious health risks, including addiction, mental illness, and overdose. Drawing on the most recent scientific and clinical evidence, this book offers a comprehensive examination of the pharmacological, medical, social, and legal aspects of NPS, with a focus on practical strategies for prevention, diagnosis, and treatment in the field of addiction medicine.
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
Kristina Adorjan, MD, Research Associate, Institute of Psychiatric Phenomics and Genomics, University Hospital, Munchen, Germany. Thomas G. Schulze, MD, Professor, Department of Psychiatry and Psychotherapy and Director, Institute of Psychiatric Phenomics and Genomics, Medical Center of the University of Munchen, Germany. Sharon L. Walsh, PhD, Professor of Behavioral Science and Director, Center on Drug and Alcohol Research, University of Kentucky, Lexington, Kentucky.
Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.
Vendeur : Grand Eagle Retail, Bensenville, IL, Etats-Unis
Paperback. Etat : new. Paperback. This book delves into the dynamic and increasingly complex world of New Psychoactive Substances (NPS). Between 2009 and 2023, more than 1,250 distinct NPS were identified worldwide, with a record number reported in 2023 alone. This surge reflects a growing diversity, particularly in the categories of synthetic opioids (notably nitazenes), cannabinoids, and stimulants. The emergence of these substances presents significant challenges for public health, lawenforcement, and regulatory frameworks, largely due to their novel chemical structures, limited detectability, and serious health risks, including addiction, mental illness, and overdose.Drawing on the most recent scientific and clinical evidence, this book offers a comprehensive examination of the pharmacological, medical, social, and legal aspects of NPS, with a focus on practical strategies for prevention, diagnosis, and treatment in the field of addiction medicine. Drawing on the latest scientific and clinical insights, the book offers a comprehensive overview of New Psychoactive Substances, addressing their pharmacological, medical, legal, and social dimensions, and providing practical strategies for prevention, diagnosis, and treatment in addiction medicine. Shipping may be from multiple locations in the US or from the UK, depending on stock availability. N° de réf. du vendeur 9780190095697
Quantité disponible : 1 disponible(s)
Vendeur : Revaluation Books, Exeter, Royaume-Uni
Paperback. Etat : Brand New. 168 pages. 6.21x0.37x9.28 inches. In Stock. N° de réf. du vendeur x-0190095695
Quantité disponible : 2 disponible(s)
Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne
Taschenbuch. Etat : Neu. Neuware - This book delves into the dynamic and increasingly complex world of New Psychoactive Substances (NPS). Between 2009 and 2023, more than 1,250 distinct NPS were identified worldwide, with a record number reported in 2023 alone. This surge reflects a growing diversity, particularly in the categories of synthetic opioids (notably nitazenes), cannabinoids, and stimulants. The emergence of these substances presents significant challenges for public health, law enforcement, and regulatory frameworks, largely due to their novel chemical structures, limited detectability, and serious health risks, including addiction, mental illness, and overdose. Drawing on the most recent scientific and clinical evidence, this book offers a comprehensive examination of the pharmacological, medical, social, and legal aspects of NPS, with a focus on practical strategies for prevention, diagnosis, and treatment in the field of addiction medicine. N° de réf. du vendeur 9780190095697
Quantité disponible : 2 disponible(s)